ELEPHAS PRESENTS NEW DATA SHOWING elive™ PLATFORM MEASURES CYTOTOXICITY ENDPOINTS IN TARGETED THERAPIES, EXTENDING PLATFORM'S POWER

New AACR D3 data mark a significant milestone for functional precision medicine, arriving as ASCO formally affirms the field as the future of care MADISON, Wis., July 24, 2026 /PRNewswire/ -- Elephas Biosciences Corporation, a private company that has developed an innovative live tissue...